Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Capital Expenditures (2024 - 2025)

Upstream Bio has reported Capital Expenditures over the past 2 years, most recently at $110000.0 for Q4 2025.

  • Quarterly results put Capital Expenditures at $110000.0 for Q4 2025, down 40.54% from a year ago — trailing twelve months through Dec 2025 was $303000.0 (changed N/A YoY), and the annual figure for FY2025 was $165000.0, down 67.71%.
  • Capital Expenditures for Q4 2025 was $110000.0 at Upstream Bio, up from $8000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for UPB hit a ceiling of $185000.0 in Q4 2024 and a floor of $8000.0 in Q3 2025.